| Price and Chart delayed at least 15 mintues. |
|
Price
$ 40.12
|
Change
0.00
|
|
Open
0.00
|
% Change
0.0%
|
|
Prev Close
40.12
|
Volume
NA
|
|
Market Value
106 bil
|
P/E Ratio
11.7
|
|
Bid
39.62
|
EPS
3.44
|
|
Ask
39.69
|
Dividend
1.46
|
|
High
0.00
|
Yield
3.6
|
|
Low
0.00
|
Shares Out
2.64 bil
|
|
52wk High
61.30
|
52wk Low
33.34
|
|
Industry: Drug Manufacturers - Major
|
|
Sector: Healthcare
|
NVS Profile
The Company provides healthcare solutions that address the evolving needs of patients & societies worldwide with a portfolio that includes innovative medicines, preventive vaccines & diagnostic tools, generic pharmaceuticals & consumer health products.
Novartis AG ADS
Lichtstrasse 35
Basel, 4056
Phone: 41 61 3241111
Fax: 41 61 3248001
Web Site: www.novartis.com
NVS Wires Headlines
|
|
| 07.02.09 |
|
ANALYSIS-Europe biotechs see light at end of funding tunnel
|
|
| 06.30.09 |
|
Medarex gets payment after Ilaris approval
|
|
| 06.29.09 |
|
FDA weighs options to reduce painkiller overdoses
|
|
| 06.25.09 |
|
Pfizer posts results from successful Sutent trial
|
|
| 06.18.09 |
|
German research points way to better anxiety drug
|
More NVS From Wires Headlines >
Forbes.com on NVS RSS
|
|
|
Novartis is ranked # 61 on the 2009 Forbes 2000 List
|
|
Thomson / IBES Earnings Estimates on NVS
Accounting Risk
Buy/Hold/Sell Analysis
Forbes Investment Guru Commentary on NVS
RSS News Feed on NVS
|
A D V E R T I S E M E N T
|